Clinical trial
Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease
NCT00065767 · University of Wisconsin, Madison, Other · Completed
Key facts
| NCT number | NCT00065767 |
|---|---|
| Title | Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease |
| Official title | Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease |
| Lead sponsor | University of Wisconsin, Madison, Other |
| Collaborators | National Institute on Aging (NIA) NIH |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Alzheimer Disease |
| Intervention type | Drug |
| Interventions | Raloxifene |
| Enrollment | 20 |
| Start date | Sep 1, 2001 |
| Primary completion | Mar 1, 2005 |
| Completion | Mar 1, 2005 |
| First posted | Aug 4, 2003 |
| Last update posted | Oct 5, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: